PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of canrespjCanadian Respiratory Journal
 
Can Respir J. 2009 Nov-Dec; 16(6): 195–197.
PMCID: PMC2807794

Language: English | French

Multiple cavitating nodules in a renal transplant recipient

Abstract

Pulmonary nodules are common following solid organ transplantation and vary in etiology. Nodules with central cavitation are most likely to be of infectious origin in the post-transplant population. A novel presentation of post-transplant lymphoproliferative disorder manifesting as multiple cavitating pulmonary nodules is described. The patient, a 45-year-old female renal transplant recipient, presented with constitutional symptoms and a chest x-ray showing multiple bilateral cavitating lesions. A computed tomography scan confirmed innumerable, randomly dispersed, cavitating nodules in the lung parenchyma. Multiple large hypodense lesions were identified in the liver and spleen. The appearance of the native and transplanted kidneys was normal. A liver biopsy identified an Epstein-Barr virus-negative, diffuse, large B cell lymphoma. Repeat imaging after treatment with a cyclophosphamide, hydroxydaunorubicin, oncovin and prednisone/prednisolone regimen demonstrated dramatic resolution of all lesions. The present case represents a unique radiographic presentation of post-transplant lymphoproliferative disorder not previously reported in the literature.

Keywords: Cavitary, Nodule, PTLD, Pulmonary, Transplant

Résumé

Les nodules pulmonaires sont courants après la greffe d’un organe solide, et leur étiologie varie. Les nodules dotés d’une cavité centrale sont plus susceptibles d’être d’origine infectieuse chez la population greffée. On décrit un cas de nouvelle présentation d’un trouble lymphoprolifératif après une greffe, se manifestant par de multiples nodules pulmonaires cavitaires. La patiente, une femme de 45 ans greffée du rein, a consulté en raison de symptômes constitutionnels et d’une radiographie pulmonaire révélant de multiples lésions cavitaires bilatérales. Une tomodensitométrie a confirmé la présence d’innombrables nodules cavitaires répartis aléatoirement dans le parenchyme pulmonaire. On a dépisté de grosses lésions hypodenses multiples dans le foie et la rate. L’apparence du rein indigène et du rein greffé était normale. Une biopsie rénale a permis de repérer un important lymphome à grosses cellules B diffus, négatif au virus d’Epstein-Barr. La reprise de l’imagerie, après le traitement à la cyclophosphamide, à l’hydroxydaunorubicine, à l’oncovine et à la prednisone et prednisolone, a révélé une résolution remarquable de toutes les lésions. Le présent cas constitue une présentation radiographique unique de trouble lymphoprolifératif après une greffe, jamais publiée auparavant.

Pulmonary nodules, either solitary or multiple, are common following solid organ transplantation and have a variety of etiologies (Table 1). Nodules with central cavitation are most likely to be of infectious origin (1). We report a unique radiographic presentation of post-transplant lymphoproliferative disorder (PTLD) manifesting as multiple cavitating pulmonary nodules in a renal transplant recipient.

Table 1
Differential diagnosis of multiple cavitating pulmonary nodules in the post-transplant setting

CASE PRESENTATION

A 45-year-old Caucasian woman with a history of renal transplantation for primary focal segmental glomerulosclerosis four years previously, presented to the emergency department with mid-epigastric pain. The patient had constitutional symptoms including fatigue, night sweats, intermittent low-grade fevers and a 4.5 kg weight loss during the previous two months. She had no history of cough or other respiratory symptoms, and a review of systems was otherwise negative. She had not travelled recently, and had no HIV risk factors or known exposure to tuberculosis. There were no recent changes to her medications, which included tacrolimus, mycophenolate mofetil, fosinopril, irbesartan and multivitamins.

Physical examination revealed a thin, afebrile patient with stable vital signs. She had mild epigastric tenderness to palpation and a positive Castell’s sign, with no palpable spleen. Her liver span was enlarged at 16 cm. The remainder of the examination was normal.

Initial laboratory results revealed a normocytic, normo-chromic anemia and mildly elevated creatinine that remained stable since her transplant. Other relevant laboratory work, including liver enzymes, was normal. A chest x-ray performed in the emergency room revealed multiple bilateral cavitating pulmonary nodules (Figure 1).

Figure 1)
Chest x-ray at presentation showing multiple bilateral pulmonary nodules, many with central necrosis

Given the history of the patient’s immunosuppression, an infectious etiology was considered likely; subsequently, she was admitted to the pulmonary service under respiratory isolation. A computed tomography scan of the chest demonstrated hilar and mediastinal adenopathy as well as innumerable bilateral cavitating nodules in the lung parenchyma, varying in size from 5 mm to 25 mm (Figure 2A). Multiple, large hypodense lesions were identified in the liver and spleen (Figure 2B). The appearance of the native and transplanted kidneys was normal.

Figure 2)
A Computed tomography scan of the chest showing numerous cavitating pulmonary nodules dispersed randomly throughout both lung fields. B Computed tomography scan of the upper abdomen showing multiple hypodensities in the liver and spleen

A core needle biopsy from one of the liver lesions revealed an Epstein-Barr virus (EBV)-negative, diffuse, large B cell lymphoma. This finding was confirmed on a subsequent bone marrow biopsy.

In keeping with treatment recommendations for PTLD, the immunosuppressives were reduced (mycophenolate mofetil was discontinued and the dose of tacrolimus decreased). However, the lesions did not respond; subsequently, a course of single-agent rituximab was attempted. This was also ineffective and the patient subsequently received eight cycles of cyclophosphamide, hydroxydaunorubicin, oncovin and prednisone/prednisolone chemotherapy. A chest x-ray and computed tomography scan performed three months later showed complete resolution of her disease (Figures 3 and and44).

Figure 3)
Chest x-ray after chemotherapy showing resolution of disease
Figure 4)
A Computed tomography scan of the chest showing clearing of all nodules at three months following chemotherapy. B Views of the upper abdomen also show dramatic resolution of the liver and splenic lesions

DISCUSSION

We believe the present case illustrates a unique presentation of PTLD manifesting as multiple bilateral cavitating lung nodules – a finding that has not been previously reported in the literature.

The differential diagnosis of cavitating lung nodules in an immunocompromised patient is outlined in Table 1. A recent retrospective review (1) of pulmonary nodules in 55 solid organ transplant recipients found that 60% had multiple nodules, the majority of which were infectious in etiology. Thirteen per cent of all nodules were cavitary; however, the authors did not specify if any were due to PTLD.

PTLD is a severe complication of organ transplantation, occurring in only 1% of renal transplant recipients. It encompasses a spectrum of pathological entities ranging from benign polyclonal B cell hyperplasia to malignant monoclonal non-Hodgkins lymphoma. Most are EBV-related B cell neoplasms; however, tumours of T cell origin and EBV-negative tumours are well documented (2,3). In renal transplant recipients, chronic immunosuppression confers an 11.8-fold increase in the risk of malignant lymphomas over a 10-year period compared with nontransplanted controls (4).

The radiographic findings of PTLD most commonly involve the abdomen, often with hypoattenuating liver nodules, adenopathy and splenomegaly, similar to our patient (5). Twenty per cent will involve the renal allograft and 38% will involve multiple sites (2). Pulmonary parenchymal PTLD is more common in lung transplant recipients but has been previously reported in renal transplants (6,7). The most common pulmonary manifestation of PTLD is multiple, well-defined, homogeneous lung nodules with a basal predominance (1,5,8,9). An extensive literature search resulted in only one other documented case of a cavitary lung nodule in a renal transplant recipient due to PTLD (1).

The treatment of PTLD depends, in part, on the pathological diagnosis. In cases of early-onset polyclonal disease, reduction of immunosuppressive therapy is the first-line intervention. This must be balanced against the risk of allograft rejection. In tumours that fail to respond to reduction in immunosuppression, or in aggressive non-Hodgkins lymphomas (such as our patient), single-agent rituximab or combination chemotherapy and, in some cases, radiation or surgery may be indicated (10). Overall survival is 61% at five years, with the best prognosis being in localized, early polyclonal disease (2).

CONCLUSION

Our case identifies a unique radiographic presentation of a severe complication of solid organ transplantation. Although not common, PTLD should be considered in the differential diagnosis of cavitary lung nodules in transplant recipients.

REFERENCES

1. Dodd GD, III, Ledesma-Medina J, Baron RL, Fuhrman CR. Post transplant lymphoproliferative disorder: Intrathoracic manifestations. Radiology. 1992;184:65–9. [PubMed]
2. Caillard S, Lelong C, Pessione F, Moulin B, French PTLD Working Group Post transplant lymphoproliferative disorders occurring after renal transplantation in adults: Report of 230 cases from the French registry. Am J Transplant. 2006;6:2735–42. [PubMed]
3. Capello D, Rossi D, Gaidano G. Post transplant lymphoproliferative disorders: Molecular basis of disease histogenesis and pathogenesis. Hematol Oncol. 2005;23:61–7. [PubMed]
4. Opelz G, Dohler B. Lymphomas after solid organ transplantation: A collaborative transplant study report. Am J Transplant. 2004;2:222. [PubMed]
5. Burney K, Bradley M, Buckley A, Lyburn I, Rye A, Hopkins R. Post transplant lymphoproliferative disorder: A pictorial review. Austral Radiol. 2006;50:412–8. [PubMed]
6. Halkos ME, Miller JI, Mann KP, Miller DL, Gal AA. Thoracic presentations of lymphoproliferative disorders. Chest. 2004;126:2013–20. [PubMed]
7. Foroncewicz B, Mucha K, Usiekniewicz J, et al. Post transplant lymphoproliferative disorder of the lung successfully treated with surgery. Transplant Proc. 2006;38:173–6. [PubMed]
8. Collins J, Muller NL, Leung AN, et al. Epstein-Barr virus associated lymphoproliferative disease of the lung: CT and histologic findings. Radiology. 1998;208:749–59. [PubMed]
9. Carignan S, Staples CA, Muller NL. Intrathoracic lymphoproliferative disorders in the immunocompromised patient: CT findings. Radiology. 1995;197:53–8. [PubMed]
10. Frey NV, Tsai DE. The management of post transplant lymphoproliferative disorder. Med Oncol. 2007;24:125–36. [PubMed]
11. Copp DH, Godwin JD, Kirby KA, Limaye AP. Clinical and radiologic factors associated with pulmonary nodule etiology in organ transplant recipients. Am J Transplant. 2006;6:2759–64. [PubMed]

Articles from Canadian Respiratory Journal are provided here courtesy of Hindawi Publishing Corporation